"This case concerns whether a district court’s factual finding in support of its construction of a patent claim term may be reviewed de novo, as the Federal Circuit requires (and as the panel explicitly did in this case), or only for clear error, as Federal Rule of Civil Procedure 52(a) requires.
"To discuss the case, we have Prof. Kristen Osenga, who is a Professor of Law at the University of Richmond School of Law."
Law and Policy aggregators:
The Wheeler Report | WisPolitics | RightWisconsin Features | WisOpinion | Hamilton Consulting News Clips
News and Publications | Practice Sections recent blog posts | Official Notices | Board of Governors Policy Positions |
Section Public Policy Positions
Tuesday, October 28, 2014
Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc. - Post-Argument SCOTUScast
Federalist Society SCOTUScast,